Results 21 to 30 of about 247,599 (243)
Partial CFD models of cardiovascular stents [PDF]
Copyright @ 2002 Wiley BlackwellThis paper outlines the use of a partial CFD stent model in order to improve discretisation of important small features. The effects of mesh size on the performance measure are investigated.
Tesch, K, Atherton, MA
core +6 more sources
A novel method of thrombelastograph analysis aids assessment of antiplatelet therapy in percutaneous coronary intervention. [PDF]
MD (Research)Background A near-patient test of responses to antiplatelet therapy would be of great value in percutaneous coronary intervention (PCI). However, at present, there are no widely accepted tests and varied definitions of “resistance”.
Hobson, Alex
core +4 more sources
Coronary Stent Thrombosis in COVID-19 Patients: A Systematic Review of Cases Reported Worldwide
Approximately 5 million percutaneous coronary interventions are performed worldwide annually. Therefore, stent-related complications pose a serious public health concern.
Wojciech Jan Skorupski +3 more
doaj +1 more source
Stent thrombosis revisited [PDF]
The choice of antithrombotic regimes after stent implantation has increased. Complication rates have improved and in-hospital stay is reduced with the less aggressive regimes. For de novo stenting in large vessels with a good result, ticlopidine plus aspirin or even aspirin alone appears attractive.
A H, Gershlick, R K, Aggarwal
openaire +2 more sources
Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study. [PDF]
The widespread use of coronary stents has exposed a growing population to the risk of stent thrombosis, but the importance in terms of risk of ST-segment elevation myocardial infarctions (STEMIs) remains unclear.We studied five years follow-up data for 2,
Søren Lund Kristensen +12 more
doaj +1 more source
Subacute Stent Thrombosis in Intracranial Stenting [PDF]
Background and Purpose— We sought to determine the safety of intracranial stenting with respect to subacute stent thrombosis in patients being treated with standardized antiplatelet therapy. Methods— We retrospectively ...
Christian H, Riedel +4 more
openaire +2 more sources
The purpose of this study was to investigate whether biochemical parameters on admission can predict the development of acute stent thrombosis within 24 hours of presentation in patients with ST-segment elevation myocardial infarction (STEMI) who ...
Yusuf Cekici
doaj +1 more source
Stent thrombosis and drug-eluting stents [PDF]
Coronary stents have been used for the treatment of patients with coronary artery disease (CAD), and significantly improved procedural safety and are associated with a lower rate of restenosis compared with balloon angioplasty alone. Drug-eluting stents (DES) have been dominant for the treatment of CAD with efficacy in significantly reducing both ...
Takayama, Tadateru +2 more
openaire +2 more sources
Late Coronary Stent Thrombosis [PDF]
Introduced >20 years ago,1 coronary artery stents have improved the safety and particularly the efficacy of percutaneous coronary interventions (PCIs).2 Abrupt vessel closure, complicating 6% to 8% of balloon angioplasty procedures, was associated with a 5% mortality, 40% rate of myocardial infarction (MI), and 40% rate of emergency coronary artery ...
Windecker, Stephan, Meier, Bernhard
openaire +5 more sources
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. [PDF]
BACKGROUND: The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death.
Kirtane, Ajay J +14 more
core +1 more source

